NASDAQ · Healthcare · Biotechnology
AbCellera Biologics Inc.
ABCL
AbCellera Biologics Inc. CEO Carl Hansen · Market cap $1.5B.
$4.86
-0.10 · -1.92%
52w hi $6.5152w lo $1.94
Off 52w high 36.3%
76
STRONG
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
1 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $20.17
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 27 | Thermopylae Holdings Ltd. | Buy | 38,000 | $3.44 | +$131K | 54 | |
| Feb 27 | Andrew Booth | Chief Financial Officer | Buy | 42,600 | $3.42 | +$146K | 76 |
| Feb 26 | Thermopylae Holdings Ltd. | Buy | 177,457 | $3.27 | +$580K | 67 | |
| Nov 26 | John S. Montalbano | Buy | 50,000 | $3.57 | +$178K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay